1. The increasing number of surgeries and procedures being performed globally is expected to drive the growth of the local anesthesia market.
2. Technological advancements in drug delivery systems and anesthetic agents are also expected to fuel market growth.
3. The rising prevalence of chronic diseases and the growing geriatric population are creating a greater demand for local anesthesia products and services.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Drug Type, Route Of Administration, Application End-Use, |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Pfizer, GE Healthcare, Baxter International, Fresenius Kabi, B. Braun Melsungen AG, Piramal, AbbVie, Pacira BioSciences Aspen Pharmacare Holdings., Septodont, Ultracain |
1. Stringent regulatory requirements and approval processes for new anesthetic products may act as a major restraint for market growth.
2. The rise in healthcare costs and the increasing popularity of alternative pain management techniques could potentially hinder the growth of the local anesthesia market.